Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAGE | Common Stock | Award | $0 | +10K | +17.75% | $0.00 | 66.3K | Jun 15, 2021 | Direct | F1 |
transaction | SAGE | Common Stock | Tax liability | -$182K | -3.09K | -4.66% | $58.80 | 63.2K | Jun 15, 2021 | Direct | |
transaction | SAGE | Common Stock | Options Exercise | $5.4K | +12K | +18.98% | $0.45* | 75.2K | Jun 16, 2021 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | SAGE | Stock Option (Right to Buy) | Options Exercise | $0 | -12K | -20.48% | $0.00 | 46.6K | Jun 16, 2021 | Common Stock | 12K | $0.45 | Direct | F2 |
Id | Content |
---|---|
F1 | On March 25, 2020, the reporting person was granted Performance Stock Units (PSU) to acquire a total of 25,000 shares of common stock. The PSU vests upon the achievement of certain milestones, one of which was met on June 15, 2021, resulting in the vesting of the PSU as to 10,000 shares. |
F2 | The stock option award was issued pursuant to the Sage Therapeutics, Inc. 2011 Stock Option and Incentive Plan. The option vested in full on August 12, 2017. |